MR. SANJEEV VASHISHTA
MD and CEO, PathKind Diagnostics Pvt Limited

The co-promoter of PathKind Diagnostics Pvt Limited, a Company funded by the promoters of Mankind Pharma- the 4th Largest and one of the fastest growing Pharmaceutical companies in India. Before starting PathKind in January 2017, Sanjeev spearheaded SRL Diagnostics as the CEO. Currently on a mission to take superior quality diagnostics to the grass roots and help in building a healthy nation by spreading the message of “healthy India, prosperous India” and addressing the challenge of preventive cure by the horns, the man is arguably on his life’s most significant mission yet. Here is Sanjeev Vashishta’s Limelight Story.

For a country like India on the cusp of greatness, there has never been a greater need for ‘change leaders’. People with not just the zeal to take the nation ahead, but the vision, balance and resilience required to make the journey both rewarding and sustainable. The diagnostics sector - a vital ‘wing’ of the healthcare domain - is lucky to have someone who aptly fits the role and term. Sanjeev Vashishta – a visionary who is leading industry giant PathKind’s mission of transforming the Diagnostics ecosystem - is a man on whom rests more than a company’s future. For Mr. Vashishta’s big goal is to engineer a behavioural change – and a healthier ‘mindset’ – for a nation.
Sanjeev’s saga can be chronicled from the time he completed his schooling and graduation (B.Com- Hons) from Delhi. Thereafter, he completed his Company Secretary ship before doing Business Management from UBS, Panjab University, Chandigarh. He also got the exposure to undertake a few short duration courses from some International and National institutions of robust repute. He primarily focussed around Finance and Corporate Laws for the initial 15-16 years of my career – that was his initial ‘calling’For the last 15 years, though, Sanjeev has been firmly saddled in a business role.
Just like his multi-dimensional mind, his career has multiple facets. Perhaps most significantly, Sanjeev’s professional pursuits over a kaleidoscopic and eventful odyssey spanning about 30 years has afforded him unique exposures and insights into both the traditional economy such as textiles and chemicals - and the new economy such as IT, telecom and healthcare. Closely studying the evolving dynamics of each of these platforms from the vantage point of a decision-maker enriched Sanjeev’s perspectives, lending him a 360 degree grip over the management and leadership of business in general. Along the way, he got to put his versatile talents to good use, and is credited with the coveted attribute of a ‘Turnaround Specialist’ who reversed the falling fortunes of more than one enterprise. A warm and endearing personality acts as a sharp foil to his hard business side, and Sanjeev is known never to forget his ‘good friends’.

Memorable sagas usually have their share of inflexion points. For Sanjeev Vashishta, his decision to join a PSU after having worked for about 6 years in the Private Sector proved to be that ‘tipping point’ - A fateful masterstroke in the sense that it taught him to start taking big decisions early in his life. As the youngest Head of the Department that time, he picked up precious lessons and learnings around processes, protocols and effective communication, pretty much engrained in good PSUs DNA that moulded him into a better professional and make him more methodical and systems oriented.
But like all great minds, Sanjeev isn’t happy to rest on his considerable laurels. He is convinced that the best is yet to come. It comes through in the conviction in his voice when he says, “Turning point of my life? Oops - that’s a tough one. To be very honest, I am still waiting for that Eureka moment to strike. My working life has always been interesting and as mentioned earlier, I made every day count ever since I joined my first company as a Management Trainee. I always took my job seriously and assiduously worked towards creating a difference.”
Every ‘possessed achiever’ has his ‘triggers’. Life’s driving passions that make them get up in the morning. Sanjeev is a bit of an anomaly, in that sense. In his own words, “One may find it a bit philosophical but the fact of the matter is that I have never thought about having any life’s vision in the typical sense, one is expected to have. My idea of an ideal life is to derive happiness from small-small things. If trying to remain happy qualifies to be a valid vision, then perhaps that is the one for me. I believe in living by the day and take one day at a time.”
While that may sound like a ‘laissez-faire’ approach to success, it’s the reverse, actually. It is a necessary tempering of a mind that needs to stay super focussed when all hell is breaking loose left and right, and maintain the sang-froid that is a precursor to all progress. Trust Sanjeev to plan his day meticulously, so that he can get the most out of it. Like all achievers, his intense dedication stems from the passion to create something meaningful.
As a mentor guiding PathKind’s journey across uncharted territories to build a new metaphor of health and wellness in the mission, Sanjeev’s mission is certainly not short of mission.


The excitement and passion is palpable every time he speaks about it: “Imagine that in our country not even 20% of people have given their blood samples for testing even once. Not that they don’t fall sick. Perhaps, they are oblivious of the fact that 70% of the clinical decisions taken by the doctors are based on these tests/ investigations. Another reason could be non-availability of superior quality diagnostics facilities in the Tier 2, Tier 3 towns and the rural areas where over 65% of India’s population resides.” Sanjeev and his team intends to change this for good. The express goal is to reach out to the people in the remotest of the places with superior quality diagnostics services at affordable prices. In his words, “The very idea of people having to travel 50-100 miles to get good quality diagnostics services is appalling.”
The standard temptation is to stick to urban habitats – such as cities and towns – to maximize purely business goals. Not many players in the organised space have set up the centres in the hinterland for two reasons. The primary roadblock comes form of a huge dearth of MD Pathologists. Consider this: There are less than 11,000 MD- Pathologists/ Bio Chemists/ Micro-Biologists and more than 110,000 Labs in India today.. This is where Sanjeev’s mission raises its sights a notch and hits ‘noble mode’: That of taking the healing touch of good health and wellness to the farthest corners of the country.

Instead of limiting their presence only to the Metros and Tier 1 cities, Sanjeev’s team is reaching out to the masses in the smaller towns by setting up Laboratories (and not just the Collection Centres) there. Elaborates Sanjeev: “We are in the process of creating an enabling and a meaningful network of Diagnostics Labs which are manned by MD Pathologist doctors, who walk the extra mile to ensure right diagnosis is provided to the patients so that their treatment could start at an early date. Is it easy to tread on this untrodden path? Certainly not, but we are committed to making this a reality by our tenacity, perseverance and knowledge of these markets and Diagnostics.”
They say it’s not the glow of the limelight (no pun intended), but the shadows of the downside and hardships of life that reveal our true character. Sanjeev, too, has had his share. Infact, quite a few, by his own admission. But with each ‘encounter’, the persona has only emerged stronger. If he’s fallen 7 times, he has gotten up 8. So when he hits a trough, what gets him through? Confides Sanjeev, “Man proposes, God disposes. One plans for something and something entirely different happens. One falls and fails often. The problem is not in falling or failing. One must have the fortitude, conviction in self and determination to bounce back. There have been instances where the decision taken by me went quite awry. But it has never deterred me from taking decisions. I feel, the problem lies in not taking the decisions. A few decisions may go wrong but they provide us with wonderful insights. Another area worth mentioning is my nature to trust people. On a few occasions I felt short-changed, hurt and let down by those I trusted completely which obviously afflicted me with abominable pain but such instances have never deterred me from believing in people. I trust people and would continue to do so.”

As an industry, Diagnostics is still in a very nascent stage of evolution. And as a nation, India hasn’t even scratched the surface. This is what makes his initiative a need of the hour. Agrees Sanjeev : “Research suggests that there is a huge scope for those players who are willing to dig their heels for at least 15-20 years. Unfortunately, the short term approach to limit the availability of high quality diagnostics services only to the large cities may not augur well for the industry and the country in the long term. Timely diagnosis and accurate diagnosis brings huge amount of savings to the exchequer; firstly by containing the cost of treatment of any ailment before it aggravates and secondly by arresting loss of productivity. We need to acknowledge the fact that cost of diagnosis is only a fraction of cost of treatment. Therefore, we need to push the envelope by reaching out to the masses pro-actively and educate them about the virtues of preventive healthcare.”
So what makes Sanjeev’s venture a game changer for the sector? “It is our endeavour to make the diagnostics services accessible at affordable prices right at the doorsteps of the people who need the services. In a span of just little over 2 years we have set up 46 state-of-the-art labs across 5 states apart from 575 Collection Centres (until December 2019). Given the fact that in some of the geographies of our country the temperature soars upto 50 degrees in the summer months, it is our endeavour to reduce the “sample travel time” to less than 3 hours by picking the samples and ferrying them to the closest labs under strict temperature controlled packaging. We firmly believe that we are doing the right thing by going closer to the masses despite various odds and this is going to be a game changer in the longer run.”

No goal worth pursing comes easy. It’s easy to see that the road ahead for Sanjeev isn’t one of roses. But going by the steely look in his eyes, the team is ready to face adversity in the eye. Sanjeev admits that the path chosen by them is an arduous one.
He elaborates, “Opening labs in the smaller cities and towns will make the project more and more capex as well as opex intensive. Despite the fact that majority of the equipment are available on “re-agent rental” basis, yet huge investment goes into setting up the lab in the form of leasehold improvements, utilities like UPS, DG sets, IT, stable connectivity, systems and SOPs etc.


To reach out to the people in the remote areas, we need to create more and more labs which requires huge amount of investment layout. Further, this industry is becoming more and more opex oriented as one needs to incur operating expenses in the form of salaries, increased consumption (assets are not exploited optimally in the initial few years), Administrative expenses etc. Thus, the hyperbole around Diagnostics industry being ‘Asset Light’ doesn’t hold good in the current times.
Another difficulty is around sending qualified and trained people into the smaller towns / cities. It takes huge efforts to hire qualified people and train them on various aspects of running labs. This certainly increases the costs significantly.
Paradoxically, the paying proclivity of the customers/ patients in the Tier 2/3 cities is low which works as a big deterrent for many to set up high quality labs as the costs are de facto quite high and the revenues are low as compared to the larger cities.

IT connectivity is another big challenge even today when we are at the cusp of introducing 5G in our country.

Lastly, there is a huge push back from the local Labs, especially the ones that are not following quality protocols and are run by non-qualified/ un-trained people, which leaves most organised players with an odious taste.”

Despite the evident odds, Sanjeev’s mission has started robustly, and is well on its way to adding new feathers to his already decorated cap. When enquired about the milestones already crosses, Sanjeev divulges generously, “We have just commenced our journey towards making India’s diagnostics space better. We have to do a lot to be actually qualify to call it as an achievement. However, we are building the right blocks and what keeps me inspired and excited is my team’s dedication towards creating better eco-system in the diagnostics arena. It certainly is an onerous task to create an enabling network of 46 labs and 575 Collection Centres in such a short span of time despite various odds. Our National Reference Lab has been made with great passion. We have all the departments including the following:

• Bio chemistry & immune Assays
• Haematology, Immunohaematology, Coagulation & Flow Cytometry
• Clinical Pathology
• Histopathology and Cytopathology
• Micro Biology
• Serology, Automated Elisa and IFA
• Cytogenetics
• Molecular Biology
Our network of Labs and Collection Centres are quite contemporary with similar look and feel, use of technology and processes. We are proud to share that all our Collection Centres have functional toilets (you may find it very mundane but most of the Centres in our country don’t even have toilets) and all these centres follow strict hygiene protocols. All the Labs and the Collection Centres are linked through IT and thus we are able to carry out the accessions right at the remote locations which ensures that the samples do not get mixed up. We have an amazing logistics team comprising about 150 ground force team members who work hard to meet the committed Turn Around Time over 99% times.

Thanks to the Quality Orientation, we have been able to get 7 of our Labs accredited/ Certified by NABL and all the 46 labs strictly adhere to the quality/ NABL guidelines. As we go along, we will have more and more labs certified/ accredited”.

A great beginning is half the job done. So what lies ahead? What are the future milestones that Pathkind would like to cover over the next 5 to 10 years? The immediate vision revolves around becoming amongst the nation’s most trusted brand. Sanjeev wants Pathkind to be a household name in every house in the nation, which means scaling the winning formula across the length and breadth of the country, leading to a pan-India footprint. He captures it succinctly, “Our mission is to be a Trusted Brand having Pan-India footprint, making Superior Quality Diagnostics Services Accessible to the masses at Affordable Price through Innovative means. In line with our Misson statement, our endeavor is to set up labs much beyond the Tier 1 and Metro cities. As per our strategy, we pick one geography (state) at a time and go deep inside it with our Labs and Collection Centres and as soon as we are over and done with our agenda in that state/ geography, we replicate the model in the contiguous state. We are moving steadily and resolutely on our journey to have our Labs network spread across the length and breadth of the country and take Pathkind pan-India and beyond.”

A lofty goal worth of admiration that should make both PathKind and Sanjeev Vashishta unique templates of performance and a prescription for national progress - one that delivers, no questions asked. In a time when starting up is more glamorized than the rest of the odyssey, Sanjeev is making a strong case for the merits of perseverance and sustainability as well, which are equally important to success. So how does he look at his own evolutionary curve when he looks back? For the next generation of achievers, how does he want to be remembered? In short, what would his legacy be? Sanjeev takes his time to weigh the question’s various ramifications before sharing his measured and candid view:

“In line with the philosophy of our parent group- Mankind pharma, we would like to reach out to the masses with superior quality diagnostics at affordable prices. We know that the people at grass root need the diagnostics services and thus, we will have to create our own market as opposed to pouncing on the same pie. If we want India to become a healthy nation with universal health coverage, we will have to invest in the hinterland. We are doing just that and we hope the percentage of people who undertake Diagnostics tests goes beyond 50% in the near future. We have taken it upon ourselves to educate the masses around the virtues of preventive health and are working in all earnest towards reaching out to the doctors / KOLs with the latest tests/ technologies which could potentially be game changers.

We would like to be remembered as a company which tried and succeeded in taking superior quality diagnostics to the grassroots and helped in building a healthy nation by spreading the message of a ‘Healthy India, prosperous India’. Our focus would be to promote ‘preventive health’ in true sense of the words.” In this quest, Sanjeev has the warmest support of VOH.

So what has been his biggest learning? What advice would he leave to the next generation / aspirants in his domain? Says Sanjeev, “Every new day bring to us new set of challenges. Our learning is to remain true and focussed to the cause and keep on doing the right things tenaciously. As the famous adage goes, “Rome wasn’t built in a day”. If we want to change the landscape of India’s healthcare, we need to be committed to the cause and work diligently as it is a long road and an arduous journey.”

Being ‘empty nesters’ – both his sons are in the US – he and his wife (who is a Chartered Accountant by profession) spend a good part of their time reading voraciously. Of late, their reading time has been usurped by Netflix, but they still manage to catch up during the course of their travels. So what is his life’s ‘working philosophy’ – his ‘code’, so to speak? Shares Sanjeev, “Every day comes with new set of challenges; taking on these challenges head on gives me a high. Working with my wonderful team, challenging them at every step and resolving issues which need my attention is something I look forward to undertaking every day. I draw inspiration from my team members and those business associates who do the right things. I feel life is all about doing the right things and upholding the principles which are close to your heart.”

Any message to readers through the Voice of Healthcare Platform? “Stay happy and take good care of your health”, advises Sanjeev. A simple enough maxim, but often hard to implement. In the case of Sanjeev though, it’ll probably end up as another case-study of ‘Easier Done Than Said’ – the punchline that seems to define his life.

Subscribe Our Newsletter

MR. SANJAY JHA
By: - 2020-08-08 22:42:23

NEWS

Pfizer, BioNTech start combined trials of COVID-19 vaccine candidate in Japan ..

By: Reuters-20 Oct, 2020

Coronavirus and diabetes: What you need to know ..

By: Staff Writer-20 Oct, 2020

India records 46,790 new COVID-19 cases ..

By: PTI-20 Oct, 2020

50% Indians are likely to have Covid by Feb 2021, says govt-appointed panel ..

By: Reuters-20 Oct, 2020

Living coronavirus found on frozen food packaging for first time: China ..

By: PTI-19 Oct, 2020

Getting vaccine doubters to roll up their sleeves won’t be easy ..

By: Reuters-19 Oct, 2020

Latest on the worldwide spread of coronavirus ..

By: Reuters-19 Oct, 2020

AstraZeneca wins two approval recommendations from EU agency ..

By: Reuters-19 Oct, 2020

With dip in air quality in Delhi, health experts witness 15% rise in COPD/Asthma..

By: ANI-19 Oct, 2020

Global coronavirus cases surpass the 40 million milestone ..

By: Reuters-19 Oct, 2020

Pan-India covid-19 genome studies suggest virus genetically stable, no major mut..

By: PTI-18 Oct, 2020

Health expert asserts on N95 mask without valve this winter. ..

By: Joymala Bagchi , ANI.-18 Oct, 2020

Coronavirus survives on skin five times longer than flu: Study..

By: AFP-18 Oct, 2020

Treat coronavirus early to save patients’ lives, SARS veteran urges. ..

By: Jason Gale , Bloomberg-18 Oct, 2020

Long COVID 'May Be Four Syndromes' ..

By: Peter Russell-17 Oct, 2020

WHO trial to assess other antibody, antiviral drugs after remdesivir doubt. ..

By: Reuters-17 Oct, 2020

Scientists develop new method to block coronavirus replication. ..

By: PTI-17 Oct, 2020

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60...

By: Reuters-17 Oct, 2020

India's COVID-19 infection tally crosses 74 lakh with 62,212 new cases. ..

By: PTI-17 Oct, 2020

SARS-CoV-2 may use key carbohydrate to infect cells. ..

By: Erin Bryant-16 Oct, 2020

20% Rise In Death Rate Mostly Because of Pandemic. ..

By: Kathleen Doheny-16 Oct, 2020

COVID-19 Doesn’t Seem Seasonal, Study Says. ..

By: Carolyn Crist-16 Oct, 2020

Can Vitamin D treat coronavirus? UK scientists to test if 'sunshine vitamin' wil..

By: Meghna Sen-16 Oct, 2020

WHO trial results show remdesivir has little or no effect for covid-19 patients...

By: Leroy Leo-16 Oct, 2020

COVID-19 caseload in India rises to 73,70,468. ..

By: PTI-16 Oct, 2020

A healthy young person might have to wait until 2022 for covid vaccine: WHO. ..

By: Staff Writer-15 Oct, 2020

Important that Russia's Covid-19 vaccine Sputnik-V cleared by WHO: UN. ..

By: ANI-15 Oct, 2020

COVID-19 caseload in India rises to 72,39,389 ..

By: PTI-14 Oct, 2020

Aarogya Setu app helped identify coronavirus clusters, expand testing: WHO chief..

By: Meghna Sen-14 Oct, 2020

World Bank approves $12 billion for covid-19 vaccines ..

By: AFP-14 Oct, 2020

Eli Lilly pauses Covid-19 antibody treatment trial over safety concern ..

By: AFP-14 Oct, 2020

New Zealand signs deal with Pfizer, BioNTech for COVID-19 vaccine..

By: Reuters-12 Oct, 2020

Less than 1000 coronavirus deaths recorded for 8 consecutive days in India ..

By: PTI-12 Oct, 2020

Covid-19 vaccines under different trial stages in India: Harsh Vardhan ..

By: Sangeeta Ojha-12 Oct, 2020

Maintain quality testing for Covid-19 kits: Health experts ..

By: ANI-12 Oct, 2020

Maintain quality testing for Covid-19 kits: Health experts ..

By: ANI-12 Oct, 2020

COVID research updates: Dense cities should brace for long coronavirus outbreaks..

By: Anonymous-12 Oct, 2020

Coronavirus risk may go up on exposure to urban air pollutants: Study ..

By: ANI-12 Oct, 2020

UK to begin trials to test if BCG vaccine works against Covid-19 ..

By: PTI-12 Oct, 2020

Inhaled vaccines aim to fight coronavirus at its point of attack ..

By: Bloomberg-12 Oct, 2020

U.S., AstraZeneca strike deal for COVID-19 antibody treatment touted by Trump. ..

By: Heidi Ledford & Ewen Callaway-10 Oct, 2020

Covid-19 Story Tip: Biomedical Engineers Lead Efforts to Make PPE ..

By: Elizabeth Logsdon, Ph.D., and Warren Grayson, Ph.D./Johns Hopkins Medicine-10 Oct, 2020

India reports 73,272 new coronavirus cases, 926 fresh fatalities. ..

By: PTI-10 Oct, 2020

COVID-19 vaccine: Russia all set to approve second vaccine next week. ..

By: Anulekha Ray-10 Oct, 2020

COVID-19 treatment: Regeneron's antibody therapy to approved quickly, says Trump..

By: Mint Agencies-10 Oct, 2020

Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of..

By: Reuters-09 Oct, 2020

COVID-19 treatment: After Lilly, Fosun unit to begin US trial soon ..

By: Reuters-09 Oct, 2020

COVID + flu nasal spray vaccine set to start trial soon ..

By: Bloomberg-09 Oct, 2020

Moderna to apply for EU's rolling approval for COVID-19 vaccine ..

By: Staff Writer-09 Oct, 2020

Virologists who discovered hepatitis C win medicine Nobel ..

By: Ewen Callaway & Heidi Ledford-08 Oct, 2020

Pioneers of revolutionary CRISPR gene editing win chemistry Nobel ..

By: Heidi Ledford & Ewen Callaway-08 Oct, 2020

COVID-19 cases in India cross 68-lakh mark ..

By: PTI-08 Oct, 2020

COVID-19 treatment: Lilly seeks emergency use of its antibody-drug ..

By: Staff Writer-08 Oct, 2020

India declines proposal to test Russia Covid-19 vaccine Sputnik-V in large study..

By: Reuters-08 Oct, 2020

Asthma patients less likely to die from coronavirus: Study ..

By: Reuters-08 Oct, 2020

Government to launch Ayurveda and Yoga protocols for management of Covid-19 ..

By: Rhythma Kaul, Hindustan Times New Delhi-07 Oct, 2020

COVID-Linked Syndrome Seen in Kids Found in Adults..

By: Anonymous-07 Oct, 2020

Single-day spike of 61,267 COVID-19 infections, 884 fatalities: Health Ministry ..

By: PTI-07 Oct, 2020

HIV treatment has no benefit for hospitalised Covid-19 patients - report ..

By: Reuters-07 Oct, 2020

Doctors consider anti-cancer drugs as a stopgap weapon in covid battle ..

By: Neetu Chandra Sharma-07 Oct, 2020

CDC issues latest guidance on covid-19 spread. Read here ..

By: LiveMint-07 Oct, 2020

Covid-19 to place greater demand on mental health programmes: WHO ..

By: Neetu Chandra Sharma-07 Oct, 2020

COVID research updates: Massive contact-tracing effort in India reveals striking..

By: Sonu Mehta/Hindustan Times/Getty-05 Sept,2020

COVID-19 cases in India breach 66-lakh mark ..

By: PTI-05 Oct, 2020

Can cancer drugs prove helpful in treating Covid-19? ..

By: Neetu Chandra Sharma-05 Oct, 2020

Researchers develop new Covid-19 test that doesn't use scarce reagents ..

By: PTI-05 Oct, 2020

MHFI and AIIMS doctors launch web portal for mental healthcare amid COVID-19 ..

By: ANI-05 Oct, 2020

Pandemic, new platforms prompt surge in new therapists ..

By: Anne Steele , The Wall Street Journal-05 Oct, 2020

How long could I be contagious before a positive coronavirus test? ..

By: AP News-04 Oct, 2020

Single-day COVID-19 cases in India below 75,000, recovery rate rises to 83.01 pc..

By: PTI-04 Oct, 2020

Research Story Tip: Study Finds Obesity Medicine Specialists Are Using Evidence-..

By: Newsroom-04 Oct, 2020

Research Story Tip: Temperature-Sensitive, Longer-Lasting Eyedrops May Mean Less..

By: Newsroom-04 Oct, 2020

COVID-19 cases in India breach 65-lakh mark ..

By: PTI-04 Oct, 2020

Covid-19 vaccines should first go to health workers, first responders, group rec..

By: The Wall Street Journal-04 Oct, 2020

Why A Negative Test Doesn't Rule Out COVID ..

By: Brenda Goodman, MA-04 Oct, 2020

Pain relief caused by coronavirus may help explain COVID-19 spread: Scientists ..

By: PTI-03 Oct, 2020

Dr Reddy's seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 ..

By: PTI-03 Oct, 2020

Oxford covid vaccine: Canada launches real-time review of data ..

By: Reuters-03 Oct, 2020

How long a person could contagious before testing positive for covid ..

By: AP News-03 Oct, 2020

'Superspreaders' Are Driving the COVID-19 Pandemic ..

By: Ralph Ellis-03 Oct, 2020

Neanderthal genes linked with severe COVID-19 ..

By: Reuters-02 Oct, 2020

Gene mutation behind difference in COVID death rates among Indian states: Study ..

By: PTI-02 Oct, 2020

Startup bets on new coronavirus testing alternative: COVID-sniffing robots ..

By: Bloomberg-02 Oct, 2020

Mosquitoes cannot transmit the coronavirus: Study ..

By: Reuters-02 Oct, 2020

India's COVID-19 tally comes close to 64 lakh-mark; recoveries cross 53 lakh ..

By: PTI-02 Oct, 2020

The race for COVID-19 vaccine: Why this month is critical ..

By: Bloomberg-02 Oct, 2020

Latest on the worldwide spread of coronavirus ..

By: Reuters-30 Sept, 2020

India's COVID-19 caseload races past 62 lakh, recoveries surge to 51,87,825 ..

By: PTI-30 Sept, 2020

COVID-19 Vaccine Trial Shows Promise for Elderly ..

By: Brenda Goodman, MA-30 Sept, 2020

Coronavirus may deplete testosterone levels in men, say scientists ..

By: PTI-30 Sept, 2020

Russia to supply 2.5 crore doses of covid vaccines to Nepal ..

By: Agencies-30 Sept, 2020

Moderna COVID vaccine: Early study shows it working in older adults ..

By: Reuters-30 Sept, 2020

Tests reveal silent reinfections in hospital workers ..

By: Sonu Mehta/Hindustan Times via Getty-29 Sept, 2020

Can the coronavirus spread through the air? ..

By: AP-29 Sept, 2020

Covid vaccine: Russia may be the first to announce data from final trial. ..

By: Polina Nikolskaya , Polina Ivanova , Reuters-29 Sept, 2020

Russia to supply 2.5 crore doses of covid vaccines to Nepal...

By: livemint-29 Sept, 2020

COVID tally crosses 60 lakh; 1,039 more deaths ..

By: PTI-28 Sept, 2020

Covid-19: A cheaper, faster, accurate testing for coronavirus developed ..

By: ANI-28 Sept, 2020

Phase III trials of Sputnik V critical to know safety and efficacy: Lalit Kant ..

By: Neetu Chandra Sharma-28 Sept, 2020

Researchers combine heat and humidity to disinfect N95 masks for reuse ..

By: PTI-26 Sept, 2020

FDA Authorizes Point-of-Care COVID Antibody Test ..

By: Carolyn Crist-26 Sept, 2020

Novavax initiates late-stage covid-19 vaccine trial in UK ..

By: Reuters-26 Sept, 2020

India's COVID vaccine: Phase-3 trial of Covaxin to soon begin in UP's Lucknow ..

By: Staff Writer-26 Sept, 2020

WHO backed China for emergency use of COVID-19 vaccine next year ..

By: PTI-26 Sept, 2020

Johnson and Johnson COVID vaccine shows strong immune response in early trials ..

By: ANI-26 Sept, 2020

Covid vaccine: Pfizer urged to wait for November to seek authorization ..

By: Bloomberg-26 Sept, 2020

COVID-19 May Damage Blood Marrow Immune Cells ..

By: Carolyn Crist-25 Sept, 2020

How can I tell the difference between the flu and COVID-19? ..

By: AP News-25 Sept, 2020

COVID-19 vaccine: UP govt allows Covaxin trial of Covaxin in Lucknow, Gorakhpur ..

By: PTI-25 Sept, 2020

Some Covid-19 patients show signs of heart damage months later ..

By: Sarah Toy , The Wall Street Journal-25 Sept, 2020

Can I use a face shield instead of a mask? ..

By: AP News-25 Sept, 2020

Dengue vaccine: Panacea Biotec seeks review for launch after Phase II study ..

By: PTI-25 Sept, 2020

Covid-19: Daily recoveries exceed daily cases for 5th day ..

By: PTI-25 Sept, 2020

COVID-19 cases in India breach 57-lakh mark, recovery rate at 81.55 per cent ..

By: PTI-25 Sept, 2020

COVID-19 tally in India crosses 56-lakh mark ..

By: PTI-24 Sept, 2020

U.S. FDA to tighten coronavirus vaccine authorization standards ahead of electio..

By: Reuters-24 Sept, 2020

Many Metrics to Measure COVID-19, Which Are Best? ..

By: Christine Lehmann, MA-24 Sept, 2020

DCGI issues guidelines for pharma giants manufacturing Covid-19 vaccine ..

By: ANI-23 Sept, 2020

EPA Adds to List of Coronavirus-Fighting Cleaners ..

By: Jay Croft-22 Sept, 2020

Coronavirus vaccine makers see EU shield against side-effect claims. ..

By: Francesco Guarascio-22 Sept, 2020

Flu jab 'more important than ever' this winter ..

By: Michelle Roberts-22 Sept, 2020

Tracking COVID-19 with wastewater. ..

By: David A. Larsen & Krista R. Wigginton-22 Sept, 2020

Coronavirus vaccine likely to be ready for India by early 2021, says scientist...

By: Bloomberg-22 Sept, 2020

Influenza vaccine does not increase Covid-19 risk: Study...

By: Reuters-22 Sept, 2020

Coronavirus grows less deadly as doctors gain practice, drugs improve ..

By: Bloomberg-21 Sept, 2020

86,961 new COVID-19 cases in India, tally reaches 54,87,580 ..

By: PTI-21 Sept, 2020

WHO endorses protocol for coronavirus herbal medicine trials ..

By: AFP-21 Sept, 2020

TCS sets up 11 coronavirus isolation centres for employees, their dependents ..

By: PTI-21 Sept, 2020

Oxford covid vaccine: AstraZeneca denies trial subject had nerve ailment...

By: Bloomberg-18 Sept, 2020

Government to use immunisation program mechanism for covid-19 vaccine distributi..

By: Leroy Leo-18 Sept, 2020

Oxford COVID-19 vaccine: Serum Institute to start final phase of trial from Mond..

By: Anulekha Ray-19 Sept, 2020

WHO endorses protocol for coronavirus herbal medicine trials...

By: REUTERS-20 Sept, 2020

When will COVID-19 vaccines be generally available? ..

By: Reuters-18 Sept, 2020

COVID Conflicts Are Straining Relationships ..

By: Serena Gordon-18 Sept, 2020

COVID Prevention May Mean Record Low Flu Rates..

By: Dennis Thompson-18 Sept, 2020

Coffee May Slow Spread of Colon Cancer ..

By: Alan Mozes-18 Sept, 2020

Rich nations have cornered half of future Covid-19 vaccine supply: Oxfam ..

By: AFP-18 Sept, 2020

Oxford covid vaccine: AstraZeneca denies trial subject had nerve ailment..

By: Bloomberg-18 Sept, 2020

Centre approved anti-viral medicines to treat COVID-19 patients, says SC ..

By: PTI-17 Sept, 2020

Record 97,894 infections pushes India's COVID-19 tally to over 51 lakh ..

By: PTI-17 Sept, 2020

Can a Parkinson's Drug Treat Macular Degeneration? ..

By: Serena McNiff-17 Sept, 2020

US emergency approval broadens use of Gilead's COVID-19 drug remdesivir ..

By: PTI-17 Sept 2020

The poisonous history of chemotherapy ..

By: Heidi Ledford-16 Sept, 2020

Researchers highlight ‘questionable’ data in Russian coronavirus vac..

By: Alison Abbott-16 Sept, 2020

The lasting misery of coronavirus long-haulers ..

By: Michael Marshall-16 Sept, 2020

Post COVID-19, Lung Function Improves Over Time ..

By: Carolyn Crist-16 Sept, 2020

Stillbirth rate rises dramatically during pandemic ..

By: Clare Watson-16 Sept, 2020

When will there be a cure for covid? The body is still the best virus-killer ..

By: Michelle Cortez , Bloomberg-15 Sept, 2020

Pfizer’s COVID Vaccine Could Be Given in Late 2020 ..

By: Anonymous-15 Sept, 2020

Scientists relieved as coronavirus vaccine trial restarts — but question l..

By: David Cyranoski & Smriti Mallapaty-15 Sept, 2020

China coronavirus vaccine may be ready for public in November - official ..

By: Reuters-15 Sept, 2020

Latest on the worldwide spread of coronavirus ..

By: Reuters-15 Sept, 2020

Bill Gates: ‘The next big question’ is how to distribute coronavirus..

By: Noah Higgins-Dunn & Christina Farr-15 Sept, 2020

Gilead CEO: We’re studying new ways to treat coronavirus with remdesivir o..

By: Kevin Stankiewicz-15 Sept, 2020

Business leaders push for inclusivity after warning of localization and vaccine ..

By: Sam Shaed-15 Sept, 2020

Scientists publish images of coronavirus infected cells in the respiratory tract..

By: PTI-14 Sept, 2020

How pharma companies can still deliver an October coronavaccine surprise ..

By: Anonymous-13 Sept, 2020

China starts testing world's first nasal spray Covid vaccine ..

By: Anonymous-13 Sept, 2020

Over 1 lakh health IDs created under National Digital Health Mission within a mo..

By: Anonymous-13 Sept, 2020

Internet searches for symptoms can reveal covid hotspots ..

By: Anonymous-13 Sept, 2020

Oxford covid-19 vaccine: AstraZeneca must explain spinal ailment to resume trial..

By: Anonymous-12 Sept 2020

Oxford-AstraZeneca covid vaccine trials halted: 10 updates ..

By: Anonymous-12 Sept 2020

Russia Begins Rollout of COVID-19 Vaccine ..

By: Ralph Ellis-12 Sept 2020

Coronavirus research updates: Surprise! A host of tantalizing new SARS-CoV-2 pro..

By: Anonymous-12 Sept 2020

Scientists Identify New Way to Target Some Rapidly Dividing Cancer Cells, Leavin..

By: Newsroom-12 Sept 2020

COVID-19 Story Tip: Researchers Expect Viral Transmission of COVID-19 May Increa..

By: Newsroom-12 Sept 2020

Oxford covid-19 vaccine: AstraZeneca must explain spinal ailment to resume tri..

By: Mint News-10 Sep 2020

Can Plexiglass Stop COVID?..

By: Kathleen Doheny-08 Sept 2020

Companies testing vaccines pledge safety, high standards...

By: Linda A. Johnson-08 Sept 2020

Coronavirus research updates: The immune-cell traits that could predict severe C..

By: Nature-09 Sept 2020

AstraZeneca COVID-19 vaccine study paused after one illness...

By: Lauran Neergaard-09,Sept, 2020

India considering Russia's request for Phase 3 trial, production of covid vaccin..

By: Surajit Dasgupta-08, Sept, 2020

Trial Tests MMR Vaccine to Help Prevent COVID-19..

By: HealthDay Reporter-04 Sept2 020

India's COVID-19 infection tally crosses 42 lakh ..

By: PTI-08 Sept, 2020

How to fight the deadly dengue virus? Make your own mosquitoes ..

By: Jon Emont , The Wall Street Journal-08 Sept, 2020

Health-Care Startup Ro Raises $200 Million in New Funding ..

By: John McCormick-08 Sept, 2020

The Latest: Australia OKs funding for two potential vaccines ..

By: The Associated Press-08 Sept, 2020

UNICEF to lead global procurement, supply of Covid-19 vaccines ..

By: PTI-08 Sept, 2020

UN: No vaccine to be endorsed before it’s safe and effective ..

By: AP News-08 Sept, 2020

Transplanted brown-fat-like cells hold promise for obesity and diabetes ..

By: Joslin Diabetes Center-05 Sept, 2020

Russia covid vaccine produces immune response, has no side effects: Peer review ..

By: Suzi Ring , Bloomberg-05 Sept, 2020

Covid-19 vaccine developers prepare joint pledge on safety, standards ..

By: Peter Loftus-05 Sept, 2020

COVID-19 Ills No Greater for Those With Lupus, RA ..

By: Robert Preidt-05 Sept, 2020

Asthma May Not Boost Odds of Severe COVID-19 ..

By: Serena Gordon-05 Sept, 2020

Study Backs Use of Saliva COVID-19 Test ..

By: Kerry Dooley Young-05 Sept, 2020

Coronavirus research updates: Powerful new evidence links steroid treatment to l..

By: Anonymous-05 Sept, 2020

Can COVID-19 Cause Diabetes? ..

By: Anonymous-04 Sept, 2020

‘CRISPR babies’ are still too risky, says influential panel ..

By: Heidi Ledford-04 Sept, 2020

Study: COVID-19 Antibodies May Last 4 Months ..

By: WEBMD NEWS BRIEF-04 Sept, 2020

Why A Vaccine Won’t Be a Quick Fix for COVID-19 ..

By: Brenda Goodman, MA-04 Sept, 2020

Tiny Biological Package Gets Drug Right to the ‘Heart’ of Transplant..

By: Newsroom-04 Sept, 2020

India's COVID-19 tally crosses 38-lakh mark with record single-day jump of 83,88..

By: PTI-3 Sept, 2020

Steroids can save lives of critically ill Covid-19 patients: Study. ..

By: Kate Kelland , Reuters-3 Sept, 2020

India will supply coronavirus vaccines to the world - will its people benefit?..

By: Gayathri Vaidyanathan-03 Sept, 2020

Advisory Group Outlines COVID-19 Vaccine Priority...

By: Carolyn Crist-2 Sept, 2020

Covid-19 hit cancer research, funding for clinical trials. ..

By: Neetu Chandra Sharma-2 Sept, 2020

Brain Cell Death in ALS, Dementia Tied to Loss of Key Biochemical Transport Stru..

By: Newsroom-2 Sept, 2020

Coronavirus research updates: Even octogenarians develop potent antibodies..

By: Anonymous-2 Sept, 2020

Effective Cancer Immunotherapy Further Linked to Regulating a Cell ‘Suicid..

By: Newsroom-2 Sept, 2020

Study reveals immune-system deviations in severe COVID-19 cases ..

By: BRUCE GOLDMAN-2 Sept, 2020

Cancer Cells Take Over Blood Vessels to Spread ..

By: Newsroom-2 Sept, 2020

Research Story Tip: Motor Learning Processes Influence How Humans Learn New Beha..

By: Newsroom-2 Sept, 2020

GSK, partner Vir join race to find COVID-19 antibody treatment..

By: Reuters-1 Sep, 2020

COVID-19 can wipe out health care progress in short order: WHO ..

By: Reuters-1 Sep, 2020

Scientists see downsides to top COVID-19 vaccines from Russia, China ..

By: Reuters-1 Sep, 2020

Russia to vaccinate high risk groups against COVID-19 towards end of year: agenc..

By: Reuters-1 Sep, 2020

Explainer: How common cold viruses are being used in vaccines from Russia, China..

By: Reuters-1 Sep, 2020

Why deforestation and extinctions make pandemics more likely ..

By: Jeff Tollefson-1 Sep, 2020

What you need to know about the coronavirus right now ..

By: Reuters-1 Sep, 2020

Antibody therapies could be a bridge to a coronavirus vaccine - but will the wor..

By: Heidi Ledford-1 Sep, 2020

FDA commissioner says willing to fast-track COVID-19 vaccine - FT ..

By: Reuters-30 Aug, 2020

Mutated coronavirus strain found in Indonesia as cases jump. ..

By: Reuters-30 Aug, 2020

Research Story Tip: Addition by Division: Ratio of Two Proteins May Add Kidneys ..

By: Reuters-18 Aug, 2020

Fad or future? Telehealth expansion eyed beyond pandemic. ..

By: Ricardo Alonso-Zaldivar-30 Aug, 2020

India sets global record with single-day rise in coronavirus cases. ..

By: Reuters-30 Aug, 2020

Global coronavirus cases surpass 25 million - Reuters tally. ..

By: Reuters-30 Aug, 2020

Exclusive: WHO sweetens terms to join struggling global COVAX vaccine facility -..

By: Reuters-29 Aug, 2020

Moderna in talks with Japan to supply 40 million doses of COVID-19 vaccine..

By: Reuters-29 Aug, 2020

The coronavirus is most deadly if you are older and male — new data reveal..

By: Smriti Mallapaty-29 Aug, 2020

Got Fatigue? Study Further Pinpoints Brain Regions That May Control It ..

By: Newsroom-29 Aug, 2020

J&J to start mid-stage coronavirus vaccine trials in three European coun..

By: Reuters-29 Aug, 2020

Latest on the worldwide spread of coronavirus ..

By: Reuters-29 Aug, 2020

New reckoning for WHO vaccine plan as governments go it alone ..

By: Reuters-29 Aug, 2020

How India's Silicon Valley saw its COVID-19 success come undone. ..

By: Sachin Ravikumar, Derek Francis, Nivedita Bhattacharjee-26 Aug, 2020

Coronavirus research updates: Sex differences in the COVID-19 immune response mi..

By: Reuters-26 Aug, 2020

From ACTH to DNA: the rise of acronyms in research. ..

By: Giorgia Guglielmi-21 Aug, 2020

COVID-19 Story Tip: Patient Previously Diagnosed with COVID-19 Now Coping with &..

By: Reuters-25 Aug, 2020

Why IIT Alumni Council withdraws from developing COVID-19 vaccine. ..

By: Anulekha Ray-24 Aug, 2020

Russia In Touch With India To Manufacture COVID Vaccine Sputnik V: Health Minist..

By: All India | ANI-26 Aug, 2020

COVID-19 lockdowns blocked flu in some places but fall looms...

By: Andrew Meldrum, Mogomotsi Magome and Lauran Neergaard-26 Aug, 2020

Cambridge university aims for autumn trials of coronavirus vaccine after UK fund..

By: LONDON (Reuters)-26 Aug, 2020

Treating Wet Age-Related Macular Degeneration: Why Earlier Is Better ..

By: Dr. Eric Nudleman-25 Aug, 2020

Scientists decode how lungs are damaged in severe COVID-19 using imaging test ..

By: PTI-25 Aug, 2020

Serum Institute clarifies on report of covid vaccine launch in India in 10 weeks..

By: LiveMint-25 Aug, 2020

Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone ..

By: Junko Fujita-25 Aug, 2020

Survey finds most Britons reject COVID-19 'vaccine nationalism' ..

By: Reuters-25 Aug, 2020

U.S. FDA authorizes use of blood plasma to treat coronavirus ..

By: Nandita Bose, Aram Roston-25 Aug, 2020

Coronavirus Updates: Manohar Lal Khattar tests COVID-19 positive, asks colleague..

By: FP Staff-25 Aug, 2020

Study Adds to Evidence That Odor-Sensing Cells in the Nose Are the Key Entry Poi..

By: Newsroom-24 Aug, 2020

Covid-19 vaccine update: Pfizer, BioNTech release data on phase 1 trials ..

By: FE Online-24 Aug, 2020

Covid-19 vaccine update: Cuba, N Korea, Taiwan join the Coronavirus vaccine race..

By: FE Online-24 Aug, 2020

COVID-19 recovery rate reaches 74.69 per cent, case fatality dips to 1.87 per ce..

By: PTI-24 Aug, 2020

COVID-19 caseload in India crosses 30-lakh mark ..

By: PTI-24 Aug, 2020

Factbox: Latest on the worldwide spread of coronavirus..

By: Reuters-24 Aug, 2020

India crosses crucial milestone of testing over 10 lakh people in a day ..

By: PTI-23 Aug, 2020

COVID-19 diagnostic test: Saliva-based tests could be a better alternative to sw..

By: FE Online-23 Aug, 2020

COVID-19: India adds nearly 70,000 cases in 24 hours; tally nears 30-lakh mark; ..

By: FE Online-23 Aug, 2020

Novartis immuno-oncology drug candidate fails skin cancer trial ..

By: Reuters-23 Aug, 2020

US FDA-approved ointment found to treat, kill viral infections including COVID-1..

By: PTI-23 Aug, 2020

Trump says without proof that FDA 'deep state' slowing COVID trials ..

By: Reuters-23 Aug, 2020

Coronavirus Updates: Maharashtra reports 14,492 new COVID-19 cases, 326 deaths; ..

By: FP Staff-21 Aug, 2020

Russia's 'Sputnik V' COVID-19 vaccine to be tested on 40,000 people: TASS cites ..

By: Reuters-21 Aug, 2020

Asia Today: India has record high of 69,000 more infections..

By: AP-21 Aug, 2020

Endless first wave: how Indonesia failed to control coronavirus ..

By: Reuters-21 Aug, 2020

Diagnostics firms eye consolidation ..

By: livemint-21 Aug, 2020

Accuracy Problems with Widely Used Coronavirus Test, US Health Officials Warn..

By: Associated Press-21 Aug, 2020

Coronavirus is Not Ready to Budge, So When Can Children in India Go Back to Scho..

By: N C Satpathy-20 Aug, 2020

What Is Digital Health ID? Here’s What You Need to Know About Government&r..

By: Jagmeet Singh-20 Aug, 2020

How Much Vitamin C Is Too Much Vitamin C? Expert Reveals..

By: Rupali Dutta-20 Aug, 2020

One in four Indians could have been infected with the coronavirus, lab head says..

By: Savio Shetty-20 Aug, 2020

Roche, Regeneron link up on COVID-19 antibody cocktail..

By: Reuters-19 Aug, 2020

Explainer: World Health Organization's struggle for a global COVID-19 vaccine pl..

By: Reuters-19 Aug, 2020

Australia hails vaccine deal as virus surge abates..

By: Reuters-19 Aug, 2020

COVID-19: Govt to review guidelines to see if on-demand Coronavirus testing can ..

By: FE Online-19 Aug, 2020

Coronavirus vaccine update: India begins Phase 3 human trials of COVID19 vaccine..

By: FE Online-19 Aug, 2020

Immune response after mild COVID-19 is prolonged; psychiatric risk revealed..

By: Reuters-19 Aug, 2020

Recovered cases 2.93 times the number of active Covid-19 cases in country: Govt..

By: livemint-19 Aug, 2020

Study links COVID-19 to rise in childhood type 1 diabetes..

By: Reuters-19 Aug, 2020

WHO blasts 'vaccine nationalism' in last-ditch push against hoarding..

By: Reuters-19 Aug, 2020

Novavax begins mid-stage study of COVID-19 vaccine in South Africa..

By: Reuters-18 Aug, 2020

COVID-19 vaccine: Do vaccines need to be 100% effective? Fauci says otherwise..

By: FE Online-18 Aug, 2020

Russia to roll out vaccine by end of August, 1 in 2 Russian medics distrust it..

By: Financial Express-18 Aug, 2020

Testing of CanSino's COVID-19 candidate vaccine begins in Russia..

By: Reuters-18 Aug, 2020

COVID-19 warriors will be first to get vaccine post development, says Health Min..

By: PTI-18 Aug, 2020

Covid-19, Cold, Flu or Allergy: Know the symptoms..

By: HT?Correspondent Hindustan Times-17 Aug, 2020

Eat Right, Smile Bright - Acidic Food and Beverages: Impact on teeth..

By: FP Studio-17 Aug, 2020

Coronavirus Updates: Karnataka reports 7,040 new cases; health minister B Sriram..

By: FP Staff-17 Aug, 2020

Health ID pilot programme to start with 6 Union Territories..

By: FE Online-17 Aug, 2020

Mexico needs 200 million COVID-19 vaccine doses; shots could start in April..

By: Reuters-17 Aug, 2020

Factbox: Latest on worldwide coronavirus spread..

By: Reuters-17 Aug, 2020

The Latest: S. Korea reports largest virus jump since March..

By: The Associated Press-16 Aug, 2020

PM Modi announces launch of National Digital Health Mission..

By: By EH News Bureau-16 Aug, 2020

Russian doctors wary of rapidly approved Covid-19 vaccine, survey shows..

By: Reuters-16 Aug, 2020

Need to wage war against NCDs, not just COVID-19: Dr Prathap C Reddy..

By: By EH News Bureau-16 Aug, 2020

COVID-19 during pregnancy shows no affect on placental structure and pathology..

By: Dr. Liji Thomas-15 Aug, 2020

Has Delhi flattened COVID-19 curve? Widespread testing, improved health infrastr..

By: CitizeMatters.in-15 Aug, 2020

Acupuncture may help with inflammation and sepsis, a life-threatening condition ..

By: Myupchar-15 Aug, 2020

PM Modi to launch National Digital Health Mission and a unique identity number..

By: ET Bureau-15 Aug, 2020

WHO says food safe from coronavirus..

By: AFP-15 Aug, 2020

Why flu vaccines do not protect people for long..

By: ScienceMag.org-15 Aug, 2020

Amid Covid-19 fear, Delhi hospital conducts 10 liver transplants in two months..

By: ANI-14 Aug, 2020

A new way to monitor skin cancer: Scientists suggest a urine test could help tra..

By: Myupchar-14 Aug, 2020

Covid-19: Human trials of Oxford vaccine set to begin in 2 weeks, Serum Institut..

By: FE Online-14 Aug, 2020

Coronavirus India Live: Recovery rate in India best in world, fatality rate lowe..

By: FE Online-14 Aug, 2020

Zydus Cadila launches Indias cheapest remdesivir version Remdac..

By: FE Bureau-14 Aug, 2020

NHA governing board gives nod to the integration of central health schemes with ..

By: PTI-14 Aug, 2020

ePharmacies to tap approx 70 million Indian households by FY 25: FICCI report..

By: EH News Bureau-14 Aug, 2020

Novavax Reports Encouraging Vaccine Results..

By: Carolyn Crist-05 Aug, 2020

"Patients From Outside": Delhi Health Minister On Covid Tally Surge...

By: DelhiPress Trust of India-09 Aug, 2020

Billion Covid Vaccine Doses Could Be Available By End Of 2021: US Top Health Exp..

By: WorldReuters-06 Aug, 2020

New drug RLF-100 shows dramatic recovery in Covid-19 patients suffering respirat..

By: PTI-06 Aug, 2020

Biz of this immunity food not in the best of health...

By: Mayilvaganan-06 Aug, 2020

Read More

Partners & Associates